Key result
Post-renal transplant patients exhibited lower LCAT activity and higher atherogenic lipid ratios compared to healthy controls.
Why the study?
The study aimed to gain insight into HDL remodeling within the plasma compartment and the associations between LCAT and CETP activity, hsCRP, and lipid and lipoprotein concentrations and composition in post-renal transplant patients.
Cross-Sectional (n=72)
No
Answers are grounded in this paper and cite their sources.
Reduced LCAT activity may heighten post-transplant atherogenic risk; leaves open its value for risk stratification or intervention.
High-density lipoprotein (HDL) remodeling within the plasma compartment and the association between lecithin-cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP) activity, and lipid, lipoprotein concentrations and composition were investigated. The aim was to examine the high sensitivity of C-reactive protein (hsCRP), lipid, apolipoprotein B (apoB), apoAI, total apoAII, apoAIInonB, apoB-containing apoAII (apoB:AII), total apoCIII, apoCIIInonB, apoB-containing apoCIII (apoB:CIII) concentration and LCAT and CETP activity to gain an insight into the association between them and LCAT and CETP, 57 post-renal transplant (Tx) patients with and without statin therapy and in 15 healthy subjects. Tx patients had moderate hypertriglyceridemia, hypercholesterolemia, and dyslipoproteinemia, disturbed triglyceride-rich lipoproteins (TRLs) and HDL composition, decreased LCAT, and slightly increased hsCRP but no CETP activity. Spearman's correlation test showed the association between lipids and lipoproteins and LCAT or CETP, and multiple ridge stepwise forward regression showed that immunosuppressive therapy in Tx patients can disturb HDL and TRLs composition. The results suggest that inhibition or activation of LCAT is due, in part, to HDL-associated lipoprotein. Lipoprotein composition of apoAI, apoAIInonB, and apoCIIInonB in HDL particle and apoB:AII TRLs can contribute to decrease LCAT mass in Tx patients. Tx patients without statin and with lower triglycerides but higher HDL cholesterol concentration and disturbed lipoprotein composition of ApoAI and apoAII in HDL particle can decrease LCAT, increase LDL cholesterol, aggravate renal graft, and accelerate atherosclerosis and chronic heart diseases.
No takes yet. Share an insight, caveat, or question.
Kimak et al. (2013) conducted a cross-sectional in Post-renal transplantation (n=72). Renal transplantation and immunosuppressive therapy (with or without statins) vs. Healthy normolipidemic controls was evaluated on Serum lecithin-cholesterol acyltransferase (LCAT) mass activity (U/L) (p=<0.05). Post-renal transplant patients exhibited lower LCAT activity and higher atherogenic lipid ratios compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: